Tumour Burden Reporting in Phase III Clinical Trials of Metastatic Lung, Breast, and Colorectal Cancers: A Systematic Review

SIMPLE SUMMARY: The initial tumour burden is a strong and well-known prognostic factor in oncology. A systematic review was performed to examine if and how the initial tumour burden is reported in phase III clinical trials in the most frequent and deadly cancers. Seventy trials were selected, which...

Descripción completa

Detalles Bibliográficos
Autores principales: Santorsola, Mariachiara, Di Lauro, Vincenzo, Nasti, Guglielmo, Caraglia, Michele, Capuozzo, Maurizio, Perri, Francesco, Cascella, Marco, Misso, Gabriella, Ottaiano, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264965/
https://www.ncbi.nlm.nih.gov/pubmed/35805034
http://dx.doi.org/10.3390/cancers14133262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264965/
https://www.ncbi.nlm.nih.gov/pubmed/35805034
http://dx.doi.org/10.3390/cancers14133262

Ejemplares similares